Two Sigma Advisers
RCEL icon

Two Sigma Advisers’s Avita Medical RCEL Stock Holding History

Two Sigma Advisers’s Portfolio RCEL Stock Details RCEL Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q2 		– Sell
-12,000
Closed -$192K – 2635
2024
Q1 		$192K Sell
12,000
-26,700
-69% -$432K ﹤0.01% 2220
2023
Q4 		$531K Sell
38,700
-52,300
-57% -$599K ﹤0.01% 1904
2023
Q3 		$1.33M Sell
91,000
-23,600
-21% -$399K ﹤0.01% 1406
2023
Q2 		$1.95M Buy
114,600
+56,500
+97% +$829K 0.01% 1213
2023
Q1 		$812K Buy
58,100
+47,700
+459% +$507K ﹤0.01% 1735
2022
Q4 		$68.6K Buy
+10,400
New +$62.3K ﹤0.01% 2335
2020
Q2 		– Sell
-2,100
Closed -$65K – 2587
2020
Q1 		$65K Buy
+2,100
New +$87K ﹤0.01% 2356

Other funds holding RCEL

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
SCM
Soleus Capital Management Greenwich, Connecticut $2.47B AUM 115.63% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return
D.E. Shaw & Co
D.E. Shaw & Co New York $166B AUM 43.98% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

Two Sigma Advisers's RCEL Position: Q2 2024 in Review

Two Sigma Advisers sold out of Avita Medical (RCEL) in Q2 2024, closing a stake of 12,000 shares — an estimated $192K sold.

Two Sigma Advisers first reported a position in RCEL in Q1 2020 and held it in 7 quarters. The position peaked at $1.95M in Q2 2023. 68 funds tracked by Wall St. Rank hold RCEL as of Q2 2024.

  • Two Sigma Advisers reported no remaining Avita Medical position as of Q2 2024 after selling out during the quarter.
  • Two Sigma Advisers sold 12,000 Avita Medical shares in Q2 2024, an estimated $192K.
  • Two Sigma Advisers first reported a position in Avita Medical in Q1 2020 and held it in 7 quarters.
  • Two Sigma Advisers's Avita Medical position peaked at $1.95M in Q2 2023.
  • 68 funds tracked by Wall St. Rank held Avita Medical as of Q2 2024.

Based on Two Sigma Advisers's 13F filing for Q2 2024, filed 14 Aug 2024.